HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcome of LASIK in fleck corneal dystrophy.

AbstractPURPOSE:
To report the outcome of laser in situ keratomileusis (LASIK) in a patient with Fleck corneal dystrophy.
METHODS:
Case report and literature review.
RESULTS:
A 48-year-old Taiwanese man presented in November 2005, 6 years after bilateral myopic LASIK. He complained of loss of uncorrected distance visual acuity that was worse in the left eye. The patient did not report glare, halos, or other visual aberrations. Preoperative best spectacle-corrected visual acuity (BSCVA) was 20/25 OU, with a manifest refraction of -14 D OU. In November 2005, uncorrected visual acuity (UCVA) was 20/40 OD and 20/50 OS, and BSCVA was 20/25 in each eye with a manifest refraction of -1.00 sphere OD and -1.75 -1.25 x 115 OS. Slit-lamp examination was remarkable for several subtle, small, gray corneal opacities present throughout the corneal stroma. Confocal microscopy revealed refractile bodies within swollen keratocytes and normal surrounding stromal mileu. The clinical and confocal appearance was consistent with Fleck corneal dystrophy.
CONCLUSION:
In this patient with Fleck corneal dystrophy, corneal clarity and BSCVA were maintained 6 years after bilateral myopic LASIK, suggesting that LASIK does not stimulate visually significant exacerbation of Fleck corneal dystrophy.
AuthorsChristopher S Banning, Paul M Larson, J Bradley Randleman
JournalCornea (Cornea) Vol. 25 Issue 10 Pg. 1262-4 (Dec 2006) ISSN: 0277-3740 [Print] United States
PMID17172916 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Topics
  • Corneal Dystrophies, Hereditary (complications, surgery)
  • Corneal Stroma (pathology, surgery)
  • Humans
  • Keratomileusis, Laser In Situ (methods)
  • Male
  • Middle Aged
  • Myopia (complications, surgery)
  • Treatment Outcome
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: